Get the Stockscreener App
9.11
4.35%
0.38
After Hours:
8.93
-0.18
-1.98%
Cvrx Inc stock is traded at $9.11, with a volume of 237.42K.
It is up +4.35% in the last 24 hours and up +14.59% over the past month.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
See More
Previous Close:
$8.73
Open:
$8.78
24h Volume:
237.42K
Relative Volume:
0.98
Market Cap:
$238.24M
Revenue:
$47.26M
Net Income/Loss:
$-58.48M
P/E Ratio:
-3.368
EPS:
-2.7049
Net Cash Flow:
$-40.45M
1W Performance:
+14.45%
1M Performance:
+14.59%
6M Performance:
+46.94%
1Y Performance:
+8.71%
1-Day Range:
$8.65
$9.215
1-Week Range:
$7.77
$9.215
52-Week Range:
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
Name
Cvrx Inc
Sector
Industry
Phone
(763) 416-2850
Address
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
9.11 | 227.61M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
134.27 | 231.52B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
SYK
Stryker Corp
|
375.29 | 141.16B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
BSX
Boston Scientific Corp
|
96.79 | 142.10B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
MDT
Medtronic Plc
|
97.87 | 126.13B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.74 | 45.04B | 5.69B | 1.41B | 577.90M | 6.9828 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-14-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Sep-10-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-24 | Reiterated | Lake Street | Buy |
| May-01-24 | Resumed | Craig Hallum | Buy |
| May-01-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-01-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-31-23 | Initiated | Lake Street | Buy |
| Jul-18-22 | Initiated | Craig Hallum | Buy |
| Jul-26-21 | Initiated | Canaccord Genuity | Buy |
| Jul-26-21 | Initiated | Piper Sandler | Overweight |
| Jul-26-21 | Initiated | William Blair | Outperform |
View All
Cvrx Inc Stock (CVRX) Latest News
CVRx, Inc. (NASDAQ:CVRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Tick level data insight on CVRx Inc. volatilityPortfolio Value Report & Long Hold Capital Preservation Tips - newser.com
Sentiment analysis tools applied to CVRXBreakout Watch & Real-Time Chart Pattern Alerts - newser.com
Does CVRX qualify in momentum factor screeningJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - newser.com
Real time scanner hits for CVRX explainedQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
Is a relief rally coming for CVRx Inc. holders2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com
Can CVRx Inc. stock resist market sell offsJuly 2025 Sentiment & Verified Momentum Watchlists - newser.com
Smart tools for monitoring CVRX’s price actionPortfolio Risk Summary & Daily Entry Point Alerts - newser.com
$CVRX stock is up 11% today. Here's what we see in our data. - Quiver Quantitative
Long term hold vs stop loss in CVRXJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com
How to build a dashboard for CVRX stockGold Moves & High Yield Equity Trading Tips - newser.com
Visualizing CVRX stock with heatmapsQuarterly Earnings Summary & Weekly Return Optimization Alerts - newser.com
Applying Wyckoff theory to CVRX stockRate Cut & AI Optimized Trading Strategy Guides - newser.com
Is CVRx Inc a good long term investmentRisk Mitigation Techniques & Free Superior Profit Margins - earlytimes.in
CVRx Inc. stock outlook for YEARJuly 2025 Fed Impact & Low Drawdown Investment Ideas - newser.com
Chart overlay techniques for tracking CVRx Inc.Weekly Profit Recap & Weekly Watchlist of Top Performers - newser.com
Key metrics from CVRx Inc.’s quarterly dataEarnings Risk Report & Fast Gain Stock Tips - newser.com
Using data tools to time your CVRx Inc. exitWeekly Trade Analysis & Verified Momentum Watchlists - newser.com
Aug Rallies: Should I hold or sell CVRx Inc. nowEarnings Recap Summary & Expert Curated Trade Ideas - خودرو بانک
S P Trends: Can CVRx Inc expand into new marketsTrend Reversal & Weekly Watchlist for Hot Stocks - خودرو بانک
Winners Losers: Should I trade or invest in Grand Canyon Education IncPortfolio Return Summary & Advanced Technical Analysis Signals - khodrobank.com
Market Pulse: What’s the beta of CVRx Inc. stock2025 AllTime Highs & Real-Time Chart Pattern Alerts - خودرو بانک
Institutional scanner results for CVRx Inc.Dollar Strength & High Return Trade Opportunity Guides - newser.com
Sector ETF performance correlation with CVRx Inc.July 2025 Breakouts & Smart Money Movement Tracker - newser.com
Risk Off: Can CVRx Inc weather a recessionWeekly Trade Review & Daily Volume Surge Signals - خودرو بانک
Rate Cut: Is CVRx Inc stock overvalued or fairly pricedChart Signals & Precise Swing Trade Entry Alerts - خودرو بانک
Analyzing net buyer seller activity in CVRx Inc.July 2025 Spike Watch & Growth Focused Investment Plans - newser.com
Analysts Set CVRx, Inc. (NASDAQ:CVRX) Target Price at $14.00 - MarketBeat
Cvrx Inc Stock (CVRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cvrx Inc Stock (CVRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Nielsen Kirk G. | Director |
May 13 '25 |
Buy |
5.29 |
101,413 |
536,313 |
1,837,968 |
| Nielsen Kirk G. | Director |
May 14 '25 |
Buy |
5.23 |
61,200 |
320,364 |
1,899,168 |
| Nielsen Kirk G. | Director |
May 12 '25 |
Buy |
4.79 |
25,200 |
120,670 |
1,736,555 |
| Jain Mudit K. | Director |
May 12 '25 |
Buy |
4.66 |
1,500 |
6,986 |
4,900 |
| Jain Mudit K. | Director |
May 13 '25 |
Buy |
5.26 |
150 |
789 |
5,050 |
| Hykes Kevin | PRES & CEO |
May 12 '25 |
Buy |
4.84 |
5,000 |
24,200 |
133,000 |
0.65%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):